Summary of COVID-19 sentinox studies
Hide extended summaries
57 patient sentinox early treatment RCT: 67% lower progression (p=0.32) and 29% improved viral clearance (p=0.01).
RCT 57 mild COVID-19 patients showing non-significant viral load reduction with Sentinox (STX), a hypochlorous acid nasal spray. The proportion of COVID negative patients by day 5 was significantly higher in the STX-3 group than controls. Authors note that the results were likely driven by outliers with extreme baseline viral loads. When considering subjects with baseline cycle threshold values of 20–30, STX-3 showed a significant 2.01 log10 reduction. A complementary in vitro study demonstrated STX had ≥99.9% virucidal activity against various respiratory viruses including influenza, RSV, rhinovirus, adenovirus, parainfluenza, and seasonal coronavirus.
May 2022, Viruses, https://www.mdpi.com/1999-4915/14/5/1033, https://c19p.org/panatto
57 patient sentinox early treatment RCT: 67% lower progression (p=0.32) and 29% improved viral clearance (p=0.01).
RCT 57 mild COVID-19 patients showing non-significant viral load reduction with Sentinox (STX), a hypochlorous acid nasal spray. The proportion of COVID negative patients by day 5 was significantly higher in the STX-3 group than controls. Authors note that the results were likely driven by outliers with extreme baseline viral loads. When considering subjects with baseline cycle threshold values of 20–30, STX-3 showed a significant 2.01 log10 reduction. A complementary in vitro study demonstrated STX had ≥99.9% virucidal activity against various respiratory viruses including influenza, RSV, rhinovirus, adenovirus, parainfluenza, and seasonal coronavirus.
May 2022, Viruses, https://www.mdpi.com/1999-4915/14/5/1033, https://c19p.org/panatto
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. IMA and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.